Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC.TMCI · Entity 5943 | Chief Legl & Comp Off, CorpSec | September 30, 2026 | October 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TREACE MEDICAL CONCEPTS, INC.
Report date September 30, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 753,226 |
Reported balance
After 2026-09-30 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-30 · Tax withholding · Disposed 25,457 · Balance 753,226 F1: Includes 524,030 restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 524,030 restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 2, 2026 23:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Tax withholdingCommon Stock | 25,457 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-412727 · ownership.xml · nonDerivative · entry 1 Elder Scot Michael · CIK 0001916619 · Chief Legl & Comp Off, CorpSec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 753,226 F1 · balance_after: Includes 524,030 restricted stock units. Read SEC document |
| August 09, 2026 Filed Aug 12, 2026 21:30 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Tax withholdingCommon Stock | 16,253 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-347222 · ownership.xml · nonDerivative · entry 1 Elder Scot Michael · CIK 0001916619 · Chief Legl & Comp Off, CorpSec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 778,683 F1 · balance_after: Includes 590,697 restricted stock units. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 01:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Tax withholdingCommon Stock | 1,675 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-102764 · ownership.xml · nonDerivative · entry 2 Elder Scot Michael · CIK 0001916619 · Chief Legl & Comp Off, CorpSec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 794,936 F2 · balance_after: Includes 633,877 restricted stock units. Read SEC document |
| March 08, 2026 Filed Mar 12, 2026 01:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Tax withholdingCommon Stock | 175 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-102764 · ownership.xml · nonDerivative · entry 1 Elder Scot Michael · CIK 0001916619 · Chief Legl & Comp Off, CorpSec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 796,611 F1 · balance_after: Includes 640,752 restricted stock units. Read SEC document |
| January 22, 2026 Filed Jan 24, 2026 02:30 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantCommon Stock | 262,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-021452 · ownership.xml · nonDerivative · entry 2 Elder Scot Michael · CIK 0001916619 · Chief Legl & Comp Off, CorpSec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 796,786 F2 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 22, 2027 and the last installment vesting on January 22, 2030; subject to Reporting Person's providing continued service to Issuer through each vesting date. F3 · balance_after: Includes 641,470 restricted stock units. Read SEC document |
| January 22, 2026 Filed Jan 24, 2026 02:30 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Tax withholdingCommon Stock | 9,451 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-021452 · ownership.xml · nonDerivative · entry 1 Elder Scot Michael · CIK 0001916619 · Chief Legl & Comp Off, CorpSec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 534,286 F1 · balance_after: Includes 378,970 restricted stock units. Read SEC document |
| January 10, 2026 Filed Jan 14, 2026 02:30 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Tax withholdingCommon Stock | 4,544 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-012081 · ownership.xml · nonDerivative · entry 1 Elder Scot Michael · CIK 0001916619 · Chief Legl & Comp Off, CorpSec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 543,737 F1 · balance_after: Includes 410,845 restricted stock units. Read SEC document |
| October 25, 2025 Filed Oct 28, 2025 21:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Tax withholdingCommon Stock | 984 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-253800 · ownership.xml · nonDerivative · entry 1 Elder Scot Michael · CIK 0001916619 · Chief Legl & Comp Off, CorpSec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 548,281 F1 · balance_after: Includes 426,170 restricted stock units. Read SEC document |
| October 02, 2025 Filed Oct 3, 2025 01:30 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Tax withholdingCommon Stock | 650 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-228960 · ownership.xml · nonDerivative · entry 2 Elder Scot Michael · CIK 0001916619 · Chief Legl & Comp Off, CorpSec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 549,265 F2 · balance_after: Includes 428,670 restricted stock units. Read SEC document |
| September 30, 2025 Filed Oct 3, 2025 01:30 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Tax withholdingCommon Stock | 16,234 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-228960 · ownership.xml · nonDerivative · entry 1 Elder Scot Michael · CIK 0001916619 · Chief Legl & Comp Off, CorpSec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 549,915 F1 · balance_after: Includes 429,670 restricted stock units. Read SEC document |
| August 09, 2025 Filed Aug 13, 2025 01:30 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Tax withholdingCommon Stock | 10,515 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-107557 · ownership.xml · nonDerivative · entry 1 Elder Scot Michael · CIK 0001916619 · Chief Legl & Comp Off, CorpSec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 566,149 F1 · balance_after: Includes 480,103 restricted stock units. Read SEC document |
| May 08, 2025 Filed May 12, 2025 21:30 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Tax withholdingCommon Stock | 1,894 | $7.54 | $14,280.76 |
DisclosureSEC source: 0000950170-25-069492 · ownership.xml · nonDerivative · entry 2 Elder Scot Michael · CIK 0001916619 · Chief Legl & Comp Off, CorpSec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 576,664 F2 · balance_after: Includes 523,283 restricted stock units. Read SEC document |
| May 08, 2025 Filed May 12, 2025 21:30 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantCommon Stock | 7,775 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-069492 · ownership.xml · nonDerivative · entry 1 Elder Scot Michael · CIK 0001916619 · Chief Legl & Comp Off, CorpSec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 578,558 F1 · shares: Represents performance stock units ("PSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each PSU upon vesting. The PSUs vested upon the accomplishment of a performance goal related to enforcement of the Company's intellectual property rights. F2 · balance_after: Includes 523,283 restricted stock units. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 01:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Tax withholdingCommon Stock | 1,675 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-037569 · ownership.xml · nonDerivative · entry 2 Elder Scot Michael · CIK 0001916619 · Chief Legl & Comp Off, CorpSec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 570,783 F2 · balance_after: Includes 523,283 restricted stock units. Read SEC document |
| March 08, 2025 Filed Mar 12, 2025 01:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Tax withholdingCommon Stock | 176 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-037569 · ownership.xml · nonDerivative · entry 1 Elder Scot Michael · CIK 0001916619 · Chief Legl & Comp Off, CorpSec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 572,458 F1 · balance_after: Includes 530,158 restricted stock units. Read SEC document |
| January 22, 2025 Filed Jan 25, 2025 02:30 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantCommon Stock | 127,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-008972 · ownership.xml · nonDerivative · entry 1 Elder Scot Michael · CIK 0001916619 · Chief Legl & Comp Off, CorpSec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 572,634 F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 22, 2026 and the last installment vesting on January 22, 2029; subject to Reporting Person's providing continued service to Issuer through each vesting date. F2 · balance_after: Includes 530,877 restricted stock units Read SEC document |
| January 10, 2025 Filed Jan 15, 2025 02:30 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Tax withholdingCommon Stock | 4,544 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-005579 · ownership.xml · nonDerivative · entry 1 Elder Scot Michael · CIK 0001916619 · Chief Legl & Comp Off, CorpSec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 445,134 F1 · balance_after: Includes 403,327 restricted stock units. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 23:19 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Tax withholdingCommon Stock | 3,787 | $8.29 | $31,394.23 |
DisclosureSEC source: 0000950170-24-126551 · ownership.xml · nonDerivative · entry 2 Elder Scot Michael · CIK 0001916619 · Chief Legl & Comp Off, CorpSec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 449,678 F2 · balance_after: Includes 418,702 restricted stock units. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 23:19 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantCommon Stock | 15,550 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-126551 · ownership.xml · nonDerivative · entry 1 Elder Scot Michael · CIK 0001916619 · Chief Legl & Comp Off, CorpSec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 453,654 F1 · shares: Represents performance stock units ("PSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each PSU upon vesting. The PSUs vested upon the accomplishment of a performance goal related to enforcement of the Company's intellectual property rights. F2 · balance_after: Includes 418,702 restricted stock units. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 23:30 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-111853 · ownership.xml · nonDerivative · entry 1 Elder Scot Michael · CIK 0001916619 · Chief Legl & Comp Off, CorpSec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 437,915 F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in three equal annual installments on the first, second and third anniversaries of the grant date; subject to Reporting Person's providing continued service to Issuer through each vesting date. F2 · balance_after: Includes 433,637 restricted stock units. Read SEC document |
| August 09, 2024 Filed Aug 10, 2024 01:30 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantCommon Stock | 129,540 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-095007 · ownership.xml · nonDerivative · entry 1 Elder Scot Michael · CIK 0001916619 · Chief Legl & Comp Off, CorpSec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 237,915 F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in three equal annual installments on the first, second and third anniversaries of the grant date; subject to Reporting Person's providing continued service to Issuer through each vesting date. F2 · balance_after: Includes 233,637 restricted stock units. Read SEC document |
| March 10, 2024 Filed Mar 13, 2024 01:30 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Tax withholdingCommon Stock | 1,666 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-030426 · ownership.xml · nonDerivative · entry 2 Elder Scot Michael · CIK 0001916619 · Chief Legl & Comp Off, CorpSec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,375 F2 · balance_after: Includes 104,097 restricted stock units. Read SEC document |
| March 08, 2024 Filed Mar 13, 2024 01:30 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Tax withholdingCommon Stock | 169 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-030426 · ownership.xml · nonDerivative · entry 1 Elder Scot Michael · CIK 0001916619 · Chief Legl & Comp Off, CorpSec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,041 F1 · balance_after: Includes 105,763 restricted stock units. Read SEC document |
| January 10, 2024 Filed Jan 13, 2024 02:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantStock Option (Right to Buy) · Derivative | 69,050 | $0.00 Strike: $13.46 | $0.00 |
DisclosureSEC source: 0001209191-24-001592 · doc4.xml · derivative · entry 2 Elder Scot Michael · CIK 0001916619 · *See "Remarks" 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,050 Underlying: Stock Option (Right to Buy) · 69,050 shares Expires 2034-01-10 F3 · derivative.exercise_date: The stock option vests in equal annual installments over 4 years, with the first installment vesting on January 10, 2025 and the last installment vesting on January 10, 2028, subject to Reporting Person's providing continued service to Issuer through each vesting date. Read SEC document |
| January 10, 2024 Filed Jan 13, 2024 02:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantCommon Stock | 61,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-001592 · doc4.xml · nonDerivative · entry 1 Elder Scot Michael · CIK 0001916619 · *See "Remarks" 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,210 F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 10, 2025 and the last installment vesting on January 10, 2028; subject to Reporting Person's providing continued service to Issuer through each vesting date. F2 · balance_after: Includes 105,932 RSUs. Read SEC document |
| November 02, 2023 Filed Nov 4, 2023 01:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Tax withholdingCommon Stock | 609 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-054434 · doc4.xml · nonDerivative · entry 1 Elder Scot Michael · CIK 0001916619 · *See "Remarks" 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,910 F1 · balance_after: Includes 44,632 RSUs. Read SEC document |
| October 03, 2023 Filed Oct 6, 2023 01:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Tax withholdingCommon Stock | 402 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052266 · doc4.xml · nonDerivative · entry 1 Elder Scot Michael · CIK 0001916619 · *See "Remarks" 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,519 F1 · balance_after: Includes 45,241 RSUs. Read SEC document |
| March 10, 2023 Filed Mar 11, 2023 02:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantStock Option (Right to Buy) · Derivative | 62,300 | $0.00 Strike: $24.07 | $0.00 |
DisclosureSEC source: 0001209191-23-018041 · doc4.xml · derivative · entry 3 Elder Scot Michael · CIK 0001916619 · *See "Remarks" 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,300 Underlying: Stock Option (Right to Buy) · 62,300 shares Expires 2033-03-10 F5 · derivative.exercise_date: The stock option will vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date. Read SEC document |
| March 10, 2023 Filed Mar 11, 2023 02:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantCommon Stock | 27,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018041 · doc4.xml · nonDerivative · entry 2 Elder Scot Michael · CIK 0001916619 · *See "Remarks" 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,921 F3 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date. F4 · balance_after: Includes 45,643 RSUs. Read SEC document |
| March 09, 2023 Filed Mar 11, 2023 02:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | SaleCommon Stock | 177 | $24.41 | $4,320.57 |
DisclosureSEC source: 0001209191-23-018041 · doc4.xml · nonDerivative · entry 1 Elder Scot Michael · CIK 0001916619 · *See "Remarks" 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,421 F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. F2 · price: Includes 18,143 RSUs. F2 · balance_after: Includes 18,143 RSUs. Read SEC document |
| November 17, 2022 Filed Nov 18, 2022 01:23 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | PurchaseCommon Stock | 3,736 | $21.48 | $80,231.72 |
DisclosureSEC source: 0001209191-22-057743 · doc4.xml · nonDerivative · entry 1 Elder Scot Michael · CIK 0001916619 · *See "Remarks" 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,598 F1 · price: The price reported in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $21.46 to $21.49 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote F2 · balance_after: Includes 18,862 RSUs. Read SEC document |
| October 26, 2022 Filed Nov 2, 2022 12:53 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | SaleCommon Stock | 613 | $23.46 | $14,380.98 |
DisclosureSEC source: 0001209191-22-055176 · doc4.xml · nonDerivative · entry 1 Elder Scot Michael · CIK 0001916619 · *See "Remarks" 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,862 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. F2 · balance_after: Includes 18,862 RSUs. Read SEC document |
| October 01, 2022 Filed Oct 4, 2022 22:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantStock Option (Right to Buy) · Derivative | 47,000 | $0.00 Strike: $22.07 | $0.00 |
DisclosureSEC source: 0001209191-22-052447 · doc4.xml · derivative · entry 2 Elder Scot Michael · CIK 0001916619 · *See "Remarks" 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,000 Underlying: Common Stock · 47,000 shares Expires 2032-10-01 F3 · derivative.exercise_date: The stock option will vest in equal annual installments over 4 years, commencing on October 1, 2023 with the last installment on October 1, 2026 subject to Reporting Person's providing continued service to Issuer through each vesting date. Read SEC document |
| October 01, 2022 Filed Oct 4, 2022 22:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantCommon Stock | 6,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-052447 · doc4.xml · nonDerivative · entry 1 Elder Scot Michael · CIK 0001916619 · *See "Remarks" 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,475 F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on October 1, 2023 with the last installment on October 1, 2026 subject to Reporting Person's providing continued service to Issuer through each vesting date. F2 · balance_after: Includes 19,475 RSUs. Read SEC document |
| March 08, 2022 Filed Mar 14, 2022 22:07 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantStock Option (Right to Buy) · Derivative | 22,100 | $0.00 Strike: $19.15 | $0.00 |
DisclosureSEC source: 0001567619-22-006929 · doc1.xml · derivative · entry 2 Elder Scot Michael · CIK 0001916619 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,100 Underlying: Common Stock · 22,100 shares Expires 2032-03-08 F3 · derivative.exercise_date: The stock option will vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026? subject to Reporting Person's providing continued service to Issuer through each vesting date. Read SEC document |
| March 08, 2022 Filed Mar 14, 2022 22:07 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantCommon Stock | 2,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-006929 · doc1.xml · nonDerivative · entry 1 Elder Scot Michael · CIK 0001916619 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,875 F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026? subject to Reporting Person's providing continued service to Issuer through each vesting date. F2 · balance_after: Includes 12,875 RSUs. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.